Participants will gain insight into covered entity (CE) perspectives of why biosimilars are important to patient care and how contracts can impact distribution and payer decisions. Manufacturers will learn how contracting with the PVP may align with their brand strategies at various stages of the product lifecycle, including:
Thursday, July 29
12:00–1:00 PM CDT
John Barnes, CPM, MBA, 340B ACE
Associate Vice President Contract Services, 340B PVP, Apexus
National Key Account Manager at Morris & Dickson Co., LLC
Sr. Director, National Accounts Institutional at Teva Pharmaceuticals
Sr. Director, National Accounts - GPO at Coherus BioSciences
Michael O’Neal PharmD, MBA
Director of Pharmacy Procurement & Inventory Management at Vanderbilt University Medical Center
The 340B PVP Manufacturer Refund Service (MRS) facilitates refunds to covered entities by refunding directly to affected facilities, primarily through its authorized distribution network.
The Prime Vendor supports the HRSA 340B Drug Pricing Program as a voluntary program for covered entities and manufacturers.
Learn essential manufacturer compliance elements of the 340B Program at no cost, 24/7. Module descriptions available here.
Find out more about what we do and how we can help you.